Response to: 'Comments on the article: "Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial"' by Mousavi and Taherifard.

Alexis Mathian Micheline Pha Zahir Amoura

Ann Rheum Dis

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Groupement Hospitalier Pitié-Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Inserm UMRS, Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Paris, France

Published: March 2022

Download full-text PDF	Source
http://dx.doi.org/10.1136/annrheumdis-2020-217323	DOI Listing

Publication Analysis

Top Keywords

response 'comments

'comments article

article "withdrawal

"withdrawal low-dose

low-dose prednisone

prednisone sle

sle patients

patients clinically

clinically quiescent

quiescent disease

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!